BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 16877421)

  • 1. Inhibition of choroidal neovascularization by adenovirus-mediated delivery of short hairpin RNAs targeting VEGF as a potential therapy for AMD.
    Cashman SM; Bowman L; Christofferson J; Kumar-Singh R
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3496-504. PubMed ID: 16877421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
    Gu L; Chen H; Tuo J; Gao X; Chen L
    Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of gene therapy for treatment of age-related macular degeneration.
    Askou AL
    Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
    Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
    Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1-mediated delivery of a short hairpin RNA targeting vascular endothelial growth factor in human retinal pigment epithelium cells.
    Lombardi G; Calistri A; Curtarello M; Giudice GL; Piermarocchi S; Prosdocimo G; Palù G; Parolin C
    Br J Ophthalmol; 2009 Feb; 93(2):244-8. PubMed ID: 19174401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of choroidal neovascularization in mice by adeno-associated virus-delivered anti-vascular endothelial growth factor short hairpin RNA.
    Askou AL; Pournaras JA; Pihlmann M; Svalgaard JD; Arsenijevic Y; Kostic C; Bek T; Dagnaes-Hansen F; Mikkelsen JG; Jensen TG; Corydon TJ
    J Gene Med; 2012 Nov; 14(11):632-41. PubMed ID: 23080553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Short hairpin RNA targeting vascular endothelial growth factor effectively inhibits expression of vascular endothelial growth factor in human retinal pigment epithelium].
    Cai CM; Sun BC; Liu XY
    Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):334-7. PubMed ID: 16762212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
    Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2620-6. PubMed ID: 18515591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice.
    Koto T; Nagai N; Mochimaru H; Kurihara T; Izumi-Nagai K; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Oike Y; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4328-34. PubMed ID: 17724224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor.
    Baffi J; Byrnes G; Chan CC; Csaky KG
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3582-9. PubMed ID: 11006256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
    Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
    Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration.
    Honda M; Sakamoto T; Ishibashi T; Inomata H; Ueno H
    Gene Ther; 2000 Jun; 7(11):978-85. PubMed ID: 10849558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of laser-induced choroidal neovascularization by nontargeted siRNA.
    Ashikari M; Tokoro M; Itaya M; Nozaki M; Ogura Y
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3820-4. PubMed ID: 20130283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization.
    Spilsbury K; Garrett KL; Shen WY; Constable IJ; Rakoczy PE
    Am J Pathol; 2000 Jul; 157(1):135-44. PubMed ID: 10880384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
    Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of VEGF in retinal pigmented epithelial cells is not sufficient to cause choroidal neovascularization.
    Oshima Y; Oshima S; Nambu H; Kachi S; Hackett SF; Melia M; Kaleko M; Connelly S; Esumi N; Zack DJ; Campochiaro PA
    J Cell Physiol; 2004 Dec; 201(3):393-400. PubMed ID: 15389527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF.
    Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
    J Cell Physiol; 2009 Jan; 218(1):66-74. PubMed ID: 18767037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choroidal neovascularization enhanced by Chlamydia pneumoniae via Toll-like receptor 2 in the retinal pigment epithelium.
    Fujimoto T; Sonoda KH; Hijioka K; Sato K; Takeda A; Hasegawa E; Oshima Y; Ishibashi T
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4694-702. PubMed ID: 20393111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of vascular endothelial growth factor gene expression by T7-siRNAs in cultured human retinal pigment epithelial cells.
    Li GY; Fan B; Wu YZ; Wang XR; Wang YH; Wu JX
    Chin Med J (Engl); 2005 Apr; 118(7):567-73. PubMed ID: 15820087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
    Rasmussen H; Chu KW; Campochiaro P; Gehlbach PL; Haller JA; Handa JT; Nguyen QD; Sung JU
    Hum Gene Ther; 2001 Nov; 12(16):2029-32. PubMed ID: 11727737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.